Brief: Adaptive Biotechnologies Reports First Quarter 2023 Financial Results
03/05/2023 21:59
May 3 (Reuters) - Adaptive Biotechnologies Corp
ADPT.O :
* ADAPTIVE BIOTECHNOLOGIES REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS
* ADAPTIVE BIOTECHNOLOGIES - EXPECT 2023 OPERATING EXPENSES,
INCLUDING COST OF REVENUE, TO BE BELOW FULL YEAR 2022 OPERATING
EXPENSES OF $385.5 MILLION
Source text for Eikon: ID:nGNXwdtfG
Further company coverage: ADPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile